RACGP training registrars' perceptions and practice of prostate cancer screening.
OBJECTIVE
To examine the perceptions, knowledge and reported intended practice of prostate cancer screening by general practice registrars.


METHODS
A descriptive study using a mail survey of all Victorian general practice registrars and supplementary interviews.


RESULTS
The response rate to the questionnaire was 74% (n = 148). The reported correct answer for the sensitivity and specificity of digital rectal examination (DRE) and prostate specific antigen (PSA) test was 48% and 52%, and 30% and 35% respectively. Responses to questions about registrar's knowledge of screening guidelines indicated respondents believe that men aged 50 years and over should undergo annual screening. Over 50% of respondents were not familiar with any Australian guidelines for prostate cancer screening. However, reported intended practice was consistent with guidelines, with 73% of respondents indicating they would not perform a PSA test as part of a 55 year old man's check up. Qualitative interviews highlighted the importance of The Royal Australian College of General Practitioners supervisor, peer learning at release sessions, and study group preparation for college examination in their clinical decision making. Online learning and access were seen to be potential areas for further development.


CONCLUSIONS
While knowledge about the characteristics of tests for prostate cancer and Australian prostate screening guidelines is poor, most registrars practice according to current guidelines. The potential of online learning and increased access to the internet needs further study.
Tse
Justin
J
Department of General Practice, University of Melbourne, Victoria. j.tse@unimelb.edu.au
Liaw
Siaw-Teng
ST
D001315:Australia; D002983:Clinical Competence; D005194:Family Practice / Q000193:education / Q000592:standards*; D005260:Female; D006801:Humans; D008297:Male; D008505:Medical Staff, Hospital / Q000193:education / Q000592:standards*; D017410:Practice Guidelines as Topic; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000517:prevention & control*
D017430:Prostate-Specific Antigen